Deleting the hexanucleotide repeat expansions in the C9ORF72 gene using the CRISPR-Cas9 system or correcting the SOD1 or FUS gene mutations may ameliorate non-familiar ALS and FTD, or FALS respectively (Fig. 2). The gene discussed is SOD1; the disease is frontotemporal dementia.